What's Happening?
Agilent Technologies, Inc. has announced the launch of the BioTek Cytation 9 cell imaging multimode reader. This new addition to the Cytation portfolio combines multimode microplate reading with high-content cell imaging in a single platform. Designed
for researchers conducting cell-based and biochemical assays, the Cytation 9 offers expanded imaging capabilities and advanced hybrid microplate detection technologies. Key features include inverted fluorescence microscopy, upright imaging, and a multimode microplate reader module, which streamline laboratory workflows and maintain flexibility across diverse applications.
Why It's Important?
The introduction of the BioTek Cytation 9 is a significant advancement for laboratories involved in pharmaceutical and biotechnology research. By providing faster, higher-throughput capabilities and adaptable tools, the Cytation 9 supports rigorous research demands, particularly in disease and drug discovery. This innovation is poised to accelerate scientific discoveries and enhance the efficiency of research processes. Agilent's continued evolution of the Cytation product line reflects its commitment to meeting the needs of researchers and advancing the field of cell biology.
